In this large cohort study, conducted in Sweden and Norway between 2021 and 2023, researchers assessed the risk of neonatal adverse events following vaccination of pregnant women against Covid-19 with mRNA vaccines. A total of 196,470 newborns were analyzed. These children had no increased risk of adverse neonatal problems. They even had reduced risks of non-traumatic neonatal intracranial hemorrhage, hypoxic-ischemic encephalopathy and neonatal mortality. Subgroup analyses (according to vaccination context, according to health status of the newborn and according to the vaccine used) confirmed the link between Covid-19 vaccination during pregnancy and a reduction in neonatal mortality.
Source(s) :
Mikael Norman et al. Neonatal Outcomes After COVID-19 Vaccination in Pregnancy. JAMA. 2024 Feb 6;331(5):396-407. ;
Last press reviews
HIV and Dual Therapy: a promising step towards maintaining viral suppression
The introduction of dual therapies in HIV treatment marks a significant ad...
HIV and Innate Immunity: How Early Responses Shape the Evolution of Viral Reservoirs
HIV infection remains a significant challenge in the field of infectious d...